> top > docs > PMC:1064873 > spans > 15966-16822 > annotations

PMC:1064873 / 15966-16822 JSONTXT

Annnotations TAB JSON ListView MergeView

LappsTest

Id Subject Object Predicate Lexical cue
T12195 833-837 Protein denotes CD4+
T12194 811-816 Protein denotes IL-10
T12193 715-719 Protein denotes CD4+
T12192 455-460 Protein denotes IL-10
T12191 253-256 Protein denotes CRP
T12190 196-199 Protein denotes CRP
T12189 51-55 Protein denotes CD4+

2_test

Id Subject Object Predicate Lexical cue
15535835-7306232-4156889 275-277 7306232 denotes 26

biosemtest

Id Subject Object Predicate Lexical cue
T12792 195-201 UMLS/C0444497 denotes CRP l
T12791 481-491 UMLS/C1548180 denotes was signif
T12790 375-385 UMLS/C1548180 denotes without I
T12789 44-54 UMLS/C1548180 denotes ion by CD4
T12784 85-89 UMLS/C1332709 denotes stim
T12778 676-684 UMLS/C2587213 denotes 8 ± 7.9%
T12777 592-600 UMLS/C2587213 denotes ercentag
T12776 303-311 UMLS/C2587213 denotes There w
T12774 262-265 UMLS/C1413716 denotes <
T12773 203-206 UMLS/C1413716 denotes el
T12771 775-781 UMLS/C1299351 denotes of IFN
T12768 262-265 UMLS/C0006560 denotes <
T12767 203-206 UMLS/C0006560 denotes el
T12765 820-825 UMLS/C0439275 denotes n did
T12764 125-130 UMLS/C0439275 denotes L-10
T12758 841-847 UMLS/C0205307 denotes ells (
T12754 71-76 UMLS/C0231290 denotes D3 an
T12750 510-517 UMLS/C0439801 denotes the act
T12749 327-352 UMLS/C0237881 denotes ally significant differen
T12747 85-89 UMLS/C1426202 denotes stim
T12740 676-684 UMLS/C0332298 denotes 8 ± 7.9%
T12739 592-600 UMLS/C0332298 denotes ercentag
T12738 303-311 UMLS/C0332298 denotes There w
T12733 757-765 UMLS/C1705908 denotes ced high
T12732 143-151 UMLS/C1705908 denotes s with a
T12730 716-727 UMLS/C0686907 denotes D4+ T cells
T12729 574-579 UMLS/C1705429 denotes ealth
T12728 535-540 UMLS/C1705429 denotes mpare
T12727 418-424 UMLS/C1705429 denotes g. 2a)
T12726 574-579 UMLS/C1705428 denotes ealth
T12725 535-540 UMLS/C1705428 denotes mpare
T12724 418-424 UMLS/C1705428 denotes g. 2a)
T12722 775-781 UMLS/C0205250 denotes of IFN
T12716 648-656 UMLS/C0205254 denotes 45.6 ±
T12715 562-570 UMLS/C0205254 denotes group a
T12714 841-847 UMLS/C2347086 denotes ells (
T12710 262-265 UMLS/C1826658 denotes <
T12709 203-206 UMLS/C1826658 denotes el
T12705 613-621 UMLS/C0205216 denotes ctive RA
T12703 602-612 UMLS/C0439165 denotes decrease:
T12702 841-847 UMLS/C0439166 denotes ells (
T12699 574-579 UMLS/C0439745 denotes ealth
T12698 535-540 UMLS/C0439745 denotes mpare
T12697 418-424 UMLS/C0439745 denotes g. 2a)
T12694 676-684 UMLS/C0243148 denotes 8 ± 7.9%
T12693 592-600 UMLS/C0243148 denotes ercentag
T12692 303-311 UMLS/C0243148 denotes There w
T12689 262-265 UMLS/C1879974 denotes <
T12688 203-206 UMLS/C1879974 denotes el
T12685 412-417 UMLS/C0205449 denotes ps (F
T12681 195-201 UMLS/C1706309 denotes CRP l
T12678 757-765 UMLS/C1550655 denotes ced high
T12677 143-151 UMLS/C1550655 denotes s with a
T12675 574-579 UMLS/C1552839 denotes ealth
T12674 535-540 UMLS/C1552839 denotes mpare
T12673 418-424 UMLS/C1552839 denotes g. 2a)
T12672 574-579 UMLS/C1257890 denotes ealth
T12671 535-540 UMLS/C1257890 denotes mpare
T12670 418-424 UMLS/C1257890 denotes g. 2a)
T12666 676-684 UMLS/C1547100 denotes 8 ± 7.9%
T12665 592-600 UMLS/C1547100 denotes ercentag
T12664 303-311 UMLS/C1547100 denotes There w
T12661 775-781 UMLS/C1522410 denotes of IFN
T12658 510-517 UMLS/C1549649 denotes the act
T12657 841-847 UMLS/C1873497 denotes ells (
T12653 444-454 UMLS/C0021469 denotes effect of
T12647 806-814 UMLS/C0150312 denotes g/ml IL-
T12646 111-119 UMLS/C0150312 denotes e of 1 n
T12644 173-181 UMLS/C0439064 denotes e inflam
T12642 77-80 UMLS/C2698592 denotes CD
T12640 510-517 UMLS/C0449295 denotes the act
T12638 701-704 UMLS/C0349966 denotes co
T12637 426-429 UMLS/C0349966 denotes but
T12634 747-753 UMLS/C1553875 denotes ents p
T12633 623-629 UMLS/C1553875 denotes 2.9 ±
T12632 525-531 UMLS/C1553875 denotes roup a
T12530 826-831 UMLS/C1334098 denotes norma
T12529 465-470 UMLS/C1334098 denotes FN-γ
T12528 394-399 UMLS/C1334098 denotes g the
T12527 131-136 UMLS/C1334098 denotes n RA
T12523 131-136 UMLS/C1522550 denotes n RA
T12514 602-612 UMLS/C1549488 denotes decrease:
T12513 574-579 UMLS/C1552516 denotes ealth
T12512 535-540 UMLS/C1552516 denotes mpare
T12511 418-424 UMLS/C1552516 denotes g. 2a)
T12507 676-684 UMLS/C0009932 denotes 8 ± 7.9%
T12506 592-600 UMLS/C0009932 denotes ercentag
T12505 303-311 UMLS/C0009932 denotes There w
T12502 613-621 UMLS/C0547047 denotes ctive RA
T12500 775-781 UMLS/C1561957 denotes of IFN
T12499 775-781 UMLS/C1561958 denotes of IFN
T12496 757-765 UMLS/C0030705 denotes ced high
T12495 143-151 UMLS/C0030705 denotes s with a
T12492 806-814 UMLS/C0392148 denotes g/ml IL-
T12491 111-119 UMLS/C0392148 denotes e of 1 n
T12488 262-265 UMLS/C0201657 denotes <
T12487 203-206 UMLS/C0201657 denotes el
T12485 648-656 UMLS/C1705605 denotes 45.6 ±
T12484 562-570 UMLS/C1705605 denotes group a
T12480 757-765 UMLS/C1578479 denotes ced high
T12479 143-151 UMLS/C1578479 denotes s with a
T12474 757-765 UMLS/C1578483 denotes ced high
T12473 143-151 UMLS/C1578483 denotes s with a
T12469 757-765 UMLS/C1578480 denotes ced high
T12468 143-151 UMLS/C1578480 denotes s with a
T12464 757-765 UMLS/C1578481 denotes ced high
T12463 143-151 UMLS/C1578481 denotes s with a
T12460 77-80 UMLS/C0108779 denotes CD
T12457 757-765 UMLS/C1578486 denotes ced high
T12456 143-151 UMLS/C1578486 denotes s with a
T12451 757-765 UMLS/C1578485 denotes ced high
T12450 143-151 UMLS/C1578485 denotes s with a
T12447 602-612 UMLS/C1561533 denotes decrease:
T12446 164-171 UMLS/C0012634 denotes (multi
T12444 195-201 UMLS/C0392905 denotes CRP l
T12443 195-201 UMLS/C1269611 denotes CRP l
T12442 757-765 UMLS/C1578484 denotes ced high
T12441 143-151 UMLS/C1578484 denotes s with a
T12439 747-753 UMLS/C1561511 denotes ents p
T12436 623-629 UMLS/C1561511 denotes 2.9 ±
T12435 525-531 UMLS/C1561511 denotes roup a
T12434 157-163 UMLS/C1561513 denotes diseas
T12425 574-579 UMLS/C1561557 denotes ealth
T12424 535-540 UMLS/C1561557 denotes mpare
T12423 418-424 UMLS/C1561557 denotes g. 2a)
T12421 747-753 UMLS/C0205177 denotes ents p
T12420 623-629 UMLS/C0205177 denotes 2.9 ±
T12419 525-531 UMLS/C0205177 denotes roup a
T12418 157-163 UMLS/C0205177 denotes diseas
T12416 648-656 UMLS/C1608264 denotes 45.6 ±
T12415 562-570 UMLS/C1608264 denotes group a
T12413 648-656 UMLS/C1608263 denotes 45.6 ±
T12412 562-570 UMLS/C1608263 denotes group a
T12411 510-517 UMLS/C0205189 denotes the act
T12410 262-265 UMLS/C1413766 denotes <
T12409 203-206 UMLS/C1413766 denotes el
T12406 747-753 UMLS/C2347179 denotes ents p
T12405 623-629 UMLS/C2347179 denotes 2.9 ±
T12404 525-531 UMLS/C2347179 denotes roup a
T12403 157-163 UMLS/C2347179 denotes diseas
T12398 826-831 UMLS/C0085295 denotes norma
T12397 465-470 UMLS/C0085295 denotes FN-γ
T12396 394-399 UMLS/C0085295 denotes g the
T12395 131-136 UMLS/C0085295 denotes n RA
T12383 613-621 UMLS/C0392756 denotes ctive RA
T12382 841-847 UMLS/C1704701 denotes ells (
T12380 436-439 UMLS/C0005341 denotes hib
T12372 574-579 UMLS/C1522242 denotes ealth
T12371 535-540 UMLS/C1522242 denotes mpare
T12370 418-424 UMLS/C1522242 denotes g. 2a)
T12367 841-847 UMLS/C1550457 denotes ells (
T12365 157-163 UMLS/C1561511 denotes diseas
T12361 747-753 UMLS/C1561512 denotes ents p
T12360 623-629 UMLS/C1561512 denotes 2.9 ±
T12359 525-531 UMLS/C1561512 denotes roup a
T12358 157-163 UMLS/C1561512 denotes diseas
T12356 431-433 UMLS/C1553634 denotes he
T12353 747-753 UMLS/C1561513 denotes ents p
T12352 623-629 UMLS/C1561513 denotes 2.9 ±
T12351 525-531 UMLS/C1561513 denotes roup a
T12350 747-753 UMLS/C1561510 denotes ents p
T12349 623-629 UMLS/C1561510 denotes 2.9 ±
T12348 525-531 UMLS/C1561510 denotes roup a
T12347 157-163 UMLS/C1561510 denotes diseas
T12344 747-753 UMLS/C1561509 denotes ents p
T12343 623-629 UMLS/C1561509 denotes 2.9 ±
T12342 525-531 UMLS/C1561509 denotes roup a
T12341 157-163 UMLS/C1561509 denotes diseas
T12338 747-753 UMLS/C1561508 denotes ents p
T12337 623-629 UMLS/C1561508 denotes 2.9 ±
T12336 525-531 UMLS/C1561508 denotes roup a
T12335 157-163 UMLS/C1561508 denotes diseas
T12333 182-194 UMLS/C0333348 denotes atory joints
T12331 747-753 UMLS/C1561507 denotes ents p
T12330 623-629 UMLS/C1561507 denotes 2.9 ±
T12329 525-531 UMLS/C1561507 denotes roup a
T12328 157-163 UMLS/C1561507 denotes diseas
T12323 841-847 UMLS/C1551394 denotes ells (
T12321 510-517 UMLS/C2349209 denotes the act
T12631 157-163 UMLS/C1553875 denotes diseas
T12628 613-621 UMLS/C0442797 denotes ctive RA
T12623 734-741 UMLS/C0039194 denotes ctive R
T12622 63-70 UMLS/C0039194 denotes after
T12616 239-260 UMLS/C0544452 denotes in remission, CRP lev
T12615 230-246 UMLS/C0544452 denotes disease (in remi
T12612 782-788 UMLS/C0456079 denotes γ in t
T12611 266-271 UMLS/C0456079 denotes 0 mg/
T12610 207-212 UMLS/C0456079 denotes 10 m
T12609 27-33 UMLS/C0456079 denotes of IF
T12606 85-89 UMLS/C0075747 denotes stim
T12603 195-201 UMLS/C0022417 denotes CRP l
T12601 544-552 UMLS/C1707455 denotes th the i
T12600 14-22 UMLS/C1707455 denotes ed the l
T12599 353-364 UMLS/C1705242 denotes es in IFN-γ
T12596 676-684 UMLS/C1550141 denotes 8 ± 7.9%
T12595 592-600 UMLS/C1550141 denotes ercentag
T12594 303-311 UMLS/C1550141 denotes There w
T12590 353-364 UMLS/C1705241 denotes es in IFN-γ
T12586 826-831 UMLS/C1149215 denotes norma
T12585 465-470 UMLS/C1149215 denotes FN-γ
T12584 394-399 UMLS/C1149215 denotes g the
T12583 131-136 UMLS/C1149215 denotes n RA
T12574 431-433 UMLS/C0450353 denotes he
T12573 706-708 UMLS/C0450354 denotes eq
T12571 782-788 UMLS/C0441889 denotes γ in t
T12570 266-271 UMLS/C0441889 denotes 0 mg/
T12569 207-212 UMLS/C0441889 denotes 10 m
T12568 27-33 UMLS/C0441889 denotes of IF
T12562 455-461 UMLS/C2348382 denotes IL-10
T12559 574-579 UMLS/C0441833 denotes ealth
T12558 535-540 UMLS/C0441833 denotes mpare
T12557 418-424 UMLS/C0441833 denotes g. 2a)
T12551 455-461 UMLS/C1280500 denotes IL-10
T12549 510-517 UMLS/C1549479 denotes the act
T12545 71-76 UMLS/C0687676 denotes D3 an
T12541 826-831 UMLS/C1522550 denotes norma
T12540 465-470 UMLS/C1522550 denotes FN-γ
T12539 394-399 UMLS/C1522550 denotes g the
T12318 747-753 UMLS/C1547419 denotes ents p
T12317 623-629 UMLS/C1547419 denotes 2.9 ±
T12316 525-531 UMLS/C1547419 denotes roup a
T12315 157-163 UMLS/C1547419 denotes diseas
T12313 648-656 UMLS/C1547420 denotes 45.6 ±
T12312 562-570 UMLS/C1547420 denotes group a
T12308 676-684 UMLS/C1882979 denotes 8 ± 7.9%
T12307 592-600 UMLS/C1882979 denotes ercentag
T12306 303-311 UMLS/C1882979 denotes There w

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T13432 621-622 -COMMA- denotes ,
T13431 619-621 NN denotes RA
T13430 612-618 JJ denotes active
T13429 610-611 -COLON- denotes :
T13428 602-610 NN denotes decrease
T13427 591-601 NN denotes percentage
T13426 590-591 -LRB- denotes (
T13425 581-589 NN denotes controls
T13424 573-580 JJ denotes healthy
T13423 569-572 CC denotes and
T13422 563-568 NN denotes group
T13421 560-562 NN denotes RA
T13420 551-559 JJ denotes inactive
T13419 547-550 DT denotes the
T13418 542-546 IN denotes with
T13417 533-541 VB denotes compared
T13416 530-532 IN denotes as
T13415 524-529 NN denotes group
T13414 521-523 NN denotes RA
T13413 514-520 JJ denotes active
T13412 510-513 DT denotes the
T13411 507-509 IN denotes in
T13410 499-506 VB denotes limited
T13409 485-498 RB denotes significantly
T13408 481-484 VB denotes was
T13407 470-480 NN denotes production
T13406 464-469 NN denotes IFN-γ
T13405 461-463 IN denotes on
T13404 455-460 NN denotes IL-10
T13403 452-454 IN denotes of
T13402 445-451 NN denotes effect
T13401 434-444 JJ denotes inhibitory
T13400 430-433 DT denotes the
T13399 426-429 CC denotes but
T13398 424-425 -COMMA- denotes ,
T13397 423-424 -RRB- denotes )
T13396 421-423 NN denotes 2a
T13395 416-420 NNP denotes Fig.
T13394 415-416 -LRB- denotes (
T13393 408-414 NN denotes groups
T13392 402-407 CD denotes three
T13391 396-401 DT denotes these
T13390 390-395 IN denotes among
T13389 384-389 NN denotes IL-10
T13388 376-383 IN denotes without
T13387 365-375 NN denotes production
T13386 359-364 NN denotes IFN-γ
T13385 356-358 IN denotes in
T13384 344-355 NN denotes differences
T13383 332-343 JJ denotes significant
T13382 318-331 RB denotes statistically
T13381 315-317 DT denotes no
T13380 310-314 VB denotes were
T13379 304-309 EX denotes There
T13378 294-302 NN denotes controls
T13377 286-293 JJ denotes healthy
T13376 283-285 IN denotes in
T13375 279-282 CC denotes and
T13374 277-278 -RRB- denotes ]
T13373 275-277 CD denotes 26
T13372 274-275 -LRB- denotes [
T13371 272-273 -RRB- denotes )
T13370 268-272 NN denotes mg/l
T13369 265-267 CD denotes 10
T13368 263-264 SYM denotes <
T13367 257-262 NN denotes level
T13366 253-256 NN denotes CRP
T13365 251-252 -COMMA- denotes ,
T13364 242-251 NN denotes remission
T13363 239-241 IN denotes in
T13362 238-239 -LRB- denotes (
T13361 230-237 NN denotes disease
T13360 221-229 JJ denotes inactive
T13359 217-220 CC denotes and
T13358 215-216 -RRB- denotes )
T13357 211-215 NN denotes mg/l
T13356 208-210 CD denotes 10
T13355 206-207 NN denotes
T13354 200-205 NN denotes level
T13353 196-199 NN denotes CRP
T13352 194-195 -COMMA- denotes ,
T13351 188-194 NN denotes joints
T13350 175-187 JJ denotes inflammatory
T13349 166-174 JJ denotes multiple
T13348 165-166 -LRB- denotes (
T13347 157-164 NN denotes disease
T13346 150-156 JJ denotes active
T13345 145-149 IN denotes with
T13344 136-144 NN denotes patients
T13343 133-135 NN denotes RA
T13342 130-132 IN denotes in
T13341 124-129 NN denotes IL-10
T13340 118-123 NN denotes ng/ml
T13339 116-117 CD denotes 1
T13338 113-115 IN denotes of
T13337 104-112 NN denotes presence
T13336 100-103 DT denotes the
T13335 97-99 IN denotes in
T13334 83-96 NN denotes costimulation
T13333 78-82 NN denotes CD28
T13332 74-77 CC denotes and
T13331 70-73 NN denotes CD3
T13330 64-69 IN denotes after
T13329 58-63 NN denotes cells
T13328 56-57 NN denotes T
T13327 51-55 JJ denotes CD4+
T13326 48-50 IN denotes by
T13325 37-47 NN denotes production
T13324 31-36 NN denotes IFN-γ
T13323 28-30 IN denotes of
T13322 21-27 NN denotes levels
T13321 17-20 DT denotes the
T13320 8-16 VB denotes compared
T13319 3-7 RB denotes thus
T13318 0-2 PRP denotes We
T13489 854-855 -RRB- denotes )
T13488 852-854 NN denotes 2a
T13487 847-851 NN denotes Fig.
T13486 846-847 -LRB- denotes (
T13485 840-845 NN denotes cells
T13484 838-839 NN denotes T
T13483 833-837 JJ denotes CD4+
T13482 826-832 JJ denotes normal
T13481 822-825 VB denotes did
T13480 817-821 IN denotes than
T13479 811-816 NN denotes IL-10
T13478 805-810 NN denotes ng/ml
T13477 803-804 CD denotes 1
T13476 800-802 IN denotes of
T13475 791-799 NN denotes presence
T13474 787-790 DT denotes the
T13473 784-786 IN denotes in
T13472 778-783 NN denotes IFN-γ
T13471 775-777 IN denotes of
T13470 768-774 NN denotes levels
T13469 761-767 JJ denotes higher
T13468 752-760 VB denotes produced
T13467 743-751 NN denotes patients
T13466 740-742 NN denotes RA
T13465 733-739 JJ denotes active
T13464 728-732 IN denotes from
T13463 722-727 NN denotes cells
T13462 720-721 NN denotes T
T13461 715-719 JJ denotes CD4+
T13460 713-714 -COMMA- denotes ,
T13459 702-713 NN denotes consequence
T13458 700-701 DT denotes a
T13457 697-699 IN denotes As
T13456 694-695 -RRB- denotes )
T13455 692-694 NN denotes 2b
T13454 687-691 NNP denotes Fig.
T13453 686-687 -LRB- denotes (
T13452 684-685 -RRB- denotes )
T13451 683-684 NN denotes %
T13450 680-683 CD denotes 7.9
T13449 678-679 -COLON- denotes ±
T13448 673-677 CD denotes 65.8
T13447 671-672 -COMMA- denotes ,
T13446 663-671 NN denotes controls
T13445 661-662 -COLON- denotes ;
T13444 660-661 NN denotes %
T13443 656-660 CD denotes 14.4
T13442 654-655 CC denotes ±
T13441 649-653 CD denotes 45.6
T13440 647-648 -COMMA- denotes ,
T13439 645-647 NN denotes RA
T13438 636-644 JJ denotes inactive
T13437 634-635 -COLON- denotes ;
T13436 633-634 NN denotes %
T13435 629-633 CD denotes 14.4
T13434 627-628 CC denotes ±
T13433 623-626 CD denotes 2.9
R6584 T13318 T13320 arg1Of We,compared
R6585 T13320 T13319 arg1Of compared,thus
R6586 T13320 T13326 arg1Of compared,by
R6587 T13320 T13330 arg1Of compared,after
R6588 T13320 T13335 arg1Of compared,in
R6589 T13322 T13320 arg2Of levels,compared
R6590 T13322 T13321 arg1Of levels,the
R6591 T13322 T13323 arg1Of levels,of
R6592 T13325 T13323 arg2Of production,of
R6593 T13325 T13324 arg1Of production,IFN-γ
R6594 T13329 T13326 arg2Of cells,by
R6595 T13329 T13327 arg1Of cells,CD4+
R6596 T13329 T13328 arg1Of cells,T
R6597 T13331 T13332 arg1Of CD3,and
R6598 T13333 T13332 arg2Of CD28,and
R6599 T13334 T13330 arg2Of costimulation,after
R6600 T13334 T13331 arg1Of costimulation,CD3
R6601 T13334 T13333 arg1Of costimulation,CD28
R6602 T13335 T13336 arg1Of in,the
R6603 T13335 T13338 arg1Of in,of
R6604 T13337 T13335 arg2Of presence,in
R6605 T13339 T13340 arg1Of 1,ng/ml
R6606 T13341 T13335 arg3Of IL-10,in
R6607 T13341 T13339 arg1Of IL-10,1
R6608 T13341 T13342 arg1Of IL-10,in
R6609 T13341 T13376 arg1Of IL-10,in
R6610 T13342 T13375 arg1Of in,and
R6611 T13344 T13343 arg1Of patients,RA
R6612 T13344 T13345 arg1Of patients,with
R6613 T13344 T13348 arg1Of patients,(
R6614 T13344 T13359 arg1Of patients,and
R6615 T13347 T13345 arg2Of disease,with
R6616 T13347 T13346 arg1Of disease,active
R6617 T13351 T13348 arg2Of joints,(
R6618 T13351 T13349 arg1Of joints,multiple
R6619 T13351 T13350 arg1Of joints,inflammatory
R6620 T13351 T13352 arg1Of joints,","
R6621 T13357 T13352 arg2Of mg/l,","
R6622 T13357 T13353 arg1Of mg/l,CRP
R6623 T13357 T13354 arg1Of mg/l,level
R6624 T13357 T13355 arg1Of mg/l,≥
R6625 T13357 T13356 arg1Of mg/l,10
R6626 T13358 T13348 arg3Of ),(
R6627 T13359 T13342 arg2Of and,in
R6628 T13361 T13359 arg2Of disease,and
R6629 T13361 T13360 arg1Of disease,inactive
R6630 T13361 T13362 arg1Of disease,(
R6631 T13361 T13372 arg1Of disease,[
R6632 T13363 T13362 arg2Of in,(
R6633 T13364 T13363 arg2Of remission,in
R6634 T13364 T13365 arg1Of remission,","
R6635 T13367 T13365 arg2Of level,","
R6636 T13367 T13366 arg1Of level,CRP
R6637 T13367 T13370 arg1Of level,mg/l
R6638 T13369 T13368 arg1Of 10,<
R6639 T13370 T13369 arg1Of mg/l,10
R6640 T13371 T13362 arg3Of ),(
R6641 T13373 T13372 arg2Of 26,[
R6642 T13374 T13372 arg3Of ],[
R6643 T13376 T13375 arg2Of in,and
R6644 T13378 T13376 arg2Of controls,in
R6645 T13378 T13377 arg1Of controls,healthy
R6646 T13379 T13380 arg1Of There,were
R6647 T13380 T13399 arg1Of were,but
R6648 T13383 T13382 arg1Of significant,statistically
R6649 T13384 T13380 arg2Of differences,were
R6650 T13384 T13381 arg1Of differences,no
R6651 T13384 T13383 arg1Of differences,significant
R6652 T13384 T13385 arg1Of differences,in
R6653 T13387 T13385 arg2Of production,in
R6654 T13387 T13386 arg1Of production,IFN-γ
R6655 T13387 T13388 arg1Of production,without
R6656 T13389 T13388 arg2Of IL-10,without
R6657 T13389 T13390 arg1Of IL-10,among
R6658 T13393 T13390 arg2Of groups,among
R6659 T13393 T13391 arg1Of groups,these
R6660 T13393 T13392 arg1Of groups,three
R6661 T13393 T13394 arg1Of groups,(
R6662 T13396 T13394 arg2Of 2a,(
R6663 T13396 T13395 arg1Of 2a,Fig.
R6664 T13397 T13394 arg3Of ),(
R6665 T13399 T13398 arg1Of but,","
R6666 T13402 T13400 arg1Of effect,the
R6667 T13402 T13401 arg1Of effect,inhibitory
R6668 T13402 T13403 arg1Of effect,of
R6669 T13402 T13405 arg1Of effect,on
R6670 T13402 T13408 arg1Of effect,was
R6671 T13402 T13410 arg2Of effect,limited
R6672 T13404 T13403 arg2Of IL-10,of
R6673 T13407 T13405 arg2Of production,on
R6674 T13407 T13406 arg1Of production,IFN-γ
R6675 T13410 T13399 arg2Of limited,but
R6676 T13410 T13408 arg2Of limited,was
R6677 T13410 T13409 arg1Of limited,significantly
R6678 T13410 T13411 arg1Of limited,in
R6679 T13410 T13416 arg1Of limited,as
R6680 T13410 T13453 arg1Of limited,(
R6681 T13415 T13411 arg2Of group,in
R6682 T13415 T13412 arg1Of group,the
R6683 T13415 T13413 arg1Of group,active
R6684 T13415 T13414 arg1Of group,RA
R6685 T13417 T13416 arg2Of compared,as
R6686 T13417 T13418 arg1Of compared,with
R6687 T13422 T13419 arg1Of group,the
R6688 T13422 T13420 arg1Of group,inactive
R6689 T13422 T13421 arg1Of group,RA
R6690 T13422 T13423 arg1Of group,and
R6691 T13423 T13418 arg2Of and,with
R6692 T13425 T13423 arg2Of controls,and
R6693 T13425 T13424 arg1Of controls,healthy
R6694 T13425 T13426 arg1Of controls,(
R6695 T13428 T13426 arg2Of decrease,(
R6696 T13428 T13427 arg1Of decrease,percentage
R6697 T13428 T13429 arg1Of decrease,:
R6698 T13431 T13429 arg2Of RA,:
R6699 T13431 T13430 arg1Of RA,active
R6700 T13431 T13432 arg1Of RA,","
R6701 T13431 T13437 arg1Of RA,;
R6702 T13433 T13434 arg1Of 2.9,±
R6703 T13435 T13434 arg2Of 14.4,±
R6704 T13436 T13432 arg2Of %,","
R6705 T13436 T13433 arg1Of %,2.9
R6706 T13436 T13435 arg1Of %,14.4
R6707 T13439 T13437 arg2Of RA,;
R6708 T13439 T13438 arg1Of RA,inactive
R6709 T13439 T13440 arg1Of RA,","
R6710 T13439 T13445 arg1Of RA,;
R6711 T13441 T13442 arg1Of 45.6,±
R6712 T13443 T13442 arg2Of 14.4,±
R6713 T13444 T13440 arg2Of %,","
R6714 T13444 T13441 arg1Of %,45.6
R6715 T13444 T13443 arg1Of %,14.4
R6716 T13446 T13445 arg2Of controls,;
R6717 T13446 T13447 arg1Of controls,","
R6718 T13451 T13447 arg2Of %,","
R6719 T13451 T13448 arg1Of %,65.8
R6720 T13451 T13449 arg1Of %,±
R6721 T13451 T13450 arg1Of %,7.9
R6722 T13452 T13426 arg3Of ),(
R6723 T13455 T13453 arg2Of 2b,(
R6724 T13455 T13454 arg1Of 2b,Fig.
R6725 T13456 T13453 arg3Of ),(
R6726 T13459 T13457 arg2Of consequence,As
R6727 T13459 T13458 arg1Of consequence,a
R6728 T13463 T13461 arg1Of cells,CD4+
R6729 T13463 T13462 arg1Of cells,T
R6730 T13463 T13464 arg1Of cells,from
R6731 T13463 T13468 arg1Of cells,produced
R6732 T13467 T13464 arg2Of patients,from
R6733 T13467 T13465 arg1Of patients,active
R6734 T13467 T13466 arg1Of patients,RA
R6735 T13468 T13457 arg1Of produced,As
R6736 T13468 T13460 arg1Of produced,","
R6737 T13468 T13473 arg1Of produced,in
R6738 T13470 T13468 arg2Of levels,produced
R6739 T13470 T13469 arg1Of levels,higher
R6740 T13470 T13471 arg1Of levels,of
R6741 T13472 T13471 arg2Of IFN-γ,of
R6742 T13475 T13473 arg2Of presence,in
R6743 T13475 T13474 arg1Of presence,the
R6744 T13475 T13476 arg1Of presence,of
R6745 T13475 T13480 arg1Of presence,than
R6746 T13477 T13478 arg1Of 1,ng/ml
R6747 T13479 T13476 arg2Of IL-10,of
R6748 T13479 T13477 arg1Of IL-10,1
R6749 T13481 T13480 arg2Of did,than
R6750 T13485 T13481 arg1Of cells,did
R6751 T13485 T13482 arg1Of cells,normal
R6752 T13485 T13483 arg1Of cells,CD4+
R6753 T13485 T13484 arg1Of cells,T
R6754 T13485 T13486 arg1Of cells,(
R6755 T13488 T13486 arg2Of 2a,(
R6756 T13488 T13487 arg1Of 2a,Fig.
R6757 T13489 T13486 arg3Of ),(

bionlp-st-ge-2016-test-proteins

Id Subject Object Predicate Lexical cue
T12913 124-129 Protein denotes IL-10
T12912 78-82 Protein denotes CD28
T12911 70-73 Protein denotes CD3
T12910 51-54 Protein denotes CD4
T12909 31-36 Protein denotes IFN-γ
T12921 833-836 Protein denotes CD4
T12920 811-816 Protein denotes IL-10
T12919 778-783 Protein denotes IFN-γ
T12918 715-718 Protein denotes CD4
T12917 464-469 Protein denotes IFN-γ
T12916 455-460 Protein denotes IL-10
T12915 384-389 Protein denotes IL-10
T12914 359-364 Protein denotes IFN-γ

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T13112 70-73 http://www.uniprot.org/uniprot/P09693 denotes CD3
T13109 70-73 http://www.uniprot.org/uniprot/P07766 denotes CD3
T13106 70-73 http://www.uniprot.org/uniprot/P04234 denotes CD3
T13103 70-73 http://www.uniprot.org/uniprot/P20963 denotes CD3
T13100 78-82 http://www.uniprot.org/uniprot/P10747 denotes CD28
T13094 833-836 http://www.uniprot.org/uniprot/P01730 denotes CD4
T13093 715-718 http://www.uniprot.org/uniprot/P01730 denotes CD4
T13092 51-54 http://www.uniprot.org/uniprot/P01730 denotes CD4
T13086 778-783 http://www.uniprot.org/uniprot/P01579 denotes IFN-γ
T13085 464-469 http://www.uniprot.org/uniprot/P01579 denotes IFN-γ
T13073 384-389 http://www.uniprot.org/uniprot/P22301 denotes IL-10
T13072 124-129 http://www.uniprot.org/uniprot/P22301 denotes IL-10
T13084 359-364 http://www.uniprot.org/uniprot/P01579 denotes IFN-γ
T13083 31-36 http://www.uniprot.org/uniprot/P01579 denotes IFN-γ
T13075 811-816 http://www.uniprot.org/uniprot/P22301 denotes IL-10
T13074 455-460 http://www.uniprot.org/uniprot/P22301 denotes IL-10

GO-CC

Id Subject Object Predicate Lexical cue
T12958 840-845 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T12957 722-727 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T12956 58-63 http://purl.obolibrary.org/obo/GO_0005623 denotes cells

GO-MF

Id Subject Object Predicate Lexical cue
T12940 811-816 http://purl.obolibrary.org/obo/GO_0005141 denotes IL-10
T12939 455-460 http://purl.obolibrary.org/obo/GO_0005141 denotes IL-10
T12938 384-389 http://purl.obolibrary.org/obo/GO_0005141 denotes IL-10
T12937 124-129 http://purl.obolibrary.org/obo/GO_0005141 denotes IL-10

sentences

Id Subject Object Predicate Lexical cue
T12803 697-856 Sentence denotes As a consequence, CD4+ T cells from active RA patients produced higher levels of IFN-γ in the presence of 1 ng/ml IL-10 than did normal CD4+ T cells (Fig. 2a).
T12802 304-696 Sentence denotes There were no statistically significant differences in IFN-γ production without IL-10 among these three groups (Fig. 2a), but the inhibitory effect of IL-10 on IFN-γ production was significantly limited in the active RA group as compared with the inactive RA group and healthy controls (percentage decrease: active RA, 2.9 ± 14.4%; inactive RA, 45.6 ± 14.4%; controls, 65.8 ± 7.9%) (Fig. 2b).
T12801 0-303 Sentence denotes We thus compared the levels of IFN-γ production by CD4+ T cells after CD3 and CD28 costimulation in the presence of 1 ng/ml IL-10 in RA patients with active disease (multiple inflammatory joints, CRP level ≥ 10 mg/l) and inactive disease (in remission, CRP level < 10 mg/l) [26] and in healthy controls.
T97 0-303 Sentence denotes We thus compared the levels of IFN-γ production by CD4+ T cells after CD3 and CD28 costimulation in the presence of 1 ng/ml IL-10 in RA patients with active disease (multiple inflammatory joints, CRP level ≥ 10 mg/l) and inactive disease (in remission, CRP level < 10 mg/l) [26] and in healthy controls.
T98 304-696 Sentence denotes There were no statistically significant differences in IFN-γ production without IL-10 among these three groups (Fig. 2a), but the inhibitory effect of IL-10 on IFN-γ production was significantly limited in the active RA group as compared with the inactive RA group and healthy controls (percentage decrease: active RA, 2.9 ± 14.4%; inactive RA, 45.6 ± 14.4%; controls, 65.8 ± 7.9%) (Fig. 2b).
T99 697-856 Sentence denotes As a consequence, CD4+ T cells from active RA patients produced higher levels of IFN-γ in the presence of 1 ng/ml IL-10 than did normal CD4+ T cells (Fig. 2a).

simple1

Id Subject Object Predicate Lexical cue
T13138 70-73 Protein denotes CD3
T13137 51-54 Protein denotes CD4
T13136 31-36 Protein denotes IFN-γ
T13148 833-836 Protein denotes CD4
T13147 811-816 Protein denotes IL-10
T13146 778-783 Protein denotes IFN-γ
T13145 715-718 Protein denotes CD4
T13144 464-469 Protein denotes IFN-γ
T13143 455-460 Protein denotes IL-10
T13142 384-389 Protein denotes IL-10
T13141 359-364 Protein denotes IFN-γ
T13140 124-129 Protein denotes IL-10
T13139 78-82 Protein denotes CD28

BioNLP16_DUT

Id Subject Object Predicate Lexical cue
T14402 470-480 Gene_expression denotes production
T14401 365-375 Gene_expression denotes production
T14400 37-47 Gene_expression denotes production
T14383 833-836 Protein denotes CD4
T14382 811-816 Protein denotes IL-10
T14381 778-783 Protein denotes IFN-γ
T14380 715-718 Protein denotes CD4
T14379 464-469 Protein denotes IFN-γ
T14378 455-460 Protein denotes IL-10
T14377 384-389 Protein denotes IL-10
T14376 359-364 Protein denotes IFN-γ
T14375 124-129 Protein denotes IL-10
T14374 78-82 Protein denotes CD28
T14373 70-73 Protein denotes CD3
T14372 51-54 Protein denotes CD4
T14371 31-36 Protein denotes IFN-γ
R7415 T14371 T14400 themeOf IFN-γ,production
R7416 T14376 T14401 themeOf IFN-γ,production
R7417 T14379 T14402 themeOf IFN-γ,production

BioNLP16_Messiy

Id Subject Object Predicate Lexical cue
T13638 752-760 Gene_expression denotes produced
T13637 470-480 Gene_expression denotes production
T13636 365-375 Gene_expression denotes production
T13635 37-47 Gene_expression denotes production
T13617 833-836 Protein denotes CD4
T13616 811-816 Protein denotes IL-10
T13615 778-783 Protein denotes IFN-γ
T13614 715-718 Protein denotes CD4
T13613 464-469 Protein denotes IFN-γ
T13612 455-460 Protein denotes IL-10
T13611 384-389 Protein denotes IL-10
T13610 359-364 Protein denotes IFN-γ
T13609 124-129 Protein denotes IL-10
T13608 78-82 Protein denotes CD28
T13607 70-73 Protein denotes CD3
T13606 51-54 Protein denotes CD4
T13605 31-36 Protein denotes IFN-γ
R6862 T13605 T13635 themeOf IFN-γ,production
R6863 T13610 T13636 themeOf IFN-γ,production
R6864 T13613 T13637 themeOf IFN-γ,production
R6865 T13615 T13638 themeOf IFN-γ,produced

DLUT931

Id Subject Object Predicate Lexical cue
T14151 761-767 Positive_regulation denotes higher
T14150 752-760 Gene_expression denotes produced
T14149 344-355 Regulation denotes differences
T14148 470-480 Gene_expression denotes production
T14147 445-451 Regulation denotes effect
T14146 365-375 Gene_expression denotes production
T14145 83-96 Negative_regulation denotes costimulation
T14144 37-47 Gene_expression denotes production
T14124 833-836 Protein denotes CD4
T14123 811-816 Protein denotes IL-10
T14122 778-783 Protein denotes IFN-γ
T14121 715-718 Protein denotes CD4
T14120 464-469 Protein denotes IFN-γ
T14119 455-460 Protein denotes IL-10
T14118 384-389 Protein denotes IL-10
T14117 359-364 Protein denotes IFN-γ
T14116 124-129 Protein denotes IL-10
T14115 78-82 Protein denotes CD28
T14114 70-73 Protein denotes CD3
T14113 51-54 Protein denotes CD4
T14112 31-36 Protein denotes IFN-γ
R7331 T14112 T14144 themeOf IFN-γ,production
R7332 T14114 T14145 themeOf CD3,costimulation
R7333 T14115 T14145 themeOf CD28,costimulation
R7334 T14117 T14146 themeOf IFN-γ,production
R7335 T14118 T14146 themeOf IL-10,production
R7336 T14119 T14147 themeOf IL-10,effect
R7337 T14119 T14148 themeOf IL-10,production
R7338 T14120 T14148 themeOf IFN-γ,production
R7339 T14122 T14150 themeOf IFN-γ,produced
R7340 T14122 T14151 themeOf IFN-γ,higher
R7349 T14146 T14149 themeOf production,differences
R7350 T14146 T14149 themeOf production,differences
R7351 T14148 T14147 themeOf production,effect
R7352 T14148 T14147 themeOf production,effect
R7353 T14150 T14151 themeOf produced,higher

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T14349 445-480 Regulation denotes effect of IL-10 on IFN-γ production
T14346 359-414 Gene_expression denotes IFN-γ production without IL-10 among these three groups
T14341 31-63 Gene_expression denotes IFN-γ production by CD4+ T cells
T14339 78-96 Positive_regulation denotes CD28 costimulation
T14338 461-480 Gene_expression denotes on IFN-γ production
T14337 445-529 Negative_regulation denotes effect of IL-10 on IFN-γ production was significantly limited in the active RA group
T14293 416-419 Protein denotes Fig
T14288 560-562 Protein denotes RA
T14287 715-751 Entity denotes CD4+ T cells from active RA patients
T14286 31-36 Protein denotes IFN-γ
T14285 48-63 Entity denotes by CD4+ T cells
T14283 70-73 Protein denotes CD3
T14281 778-783 Protein denotes IFN-γ
T14278 687-690 Protein denotes Fig
T14273 636-647 Protein denotes inactive RA
T14272 612-621 Protein denotes active RA
T14269 464-469 Protein denotes IFN-γ
T14332 740-742 Protein denotes RA
T14330 826-845 Entity denotes normal CD4+ T cells
T14329 116-144 Protein denotes 1 ng/ml IL-10 in RA patients
T14328 521-523 Protein denotes RA
T14325 384-389 Protein denotes IL-10
T14323 253-256 Protein denotes CRP
T14320 359-364 Protein denotes IFN-γ
T14309 133-135 Protein denotes RA
T14308 803-816 Protein denotes 1 ng/ml IL-10
T14299 196-199 Protein denotes CRP
T14297 78-82 Protein denotes CD28
T14296 452-460 Protein denotes of IL-10
R7392 T14269 T14338 themeOf IFN-γ,on IFN-γ production
R7394 T14286 T14341 themeOf IFN-γ,IFN-γ production by CD4+ T cells
R7395 T14296 T14349 causeOf of IL-10,effect of IL-10 on IFN-γ production
R7396 T14297 T14339 themeOf CD28,CD28 costimulation
R7400 T14320 T14346 themeOf IFN-γ,IFN-γ production without IL-10 among these three groups
R7406 T14338 T14349 themeOf on IFN-γ production,effect of IL-10 on IFN-γ production
R7408 T14349 T14337 themeOf effect of IL-10 on IFN-γ production,effect of IL-10 on IFN-γ production was significantly limited in the active RA group

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T13988 847-851 NNP denotes Fig.
T13987 846-847 -LRB- denotes (
T13986 840-845 NNS denotes cells
T13985 838-839 NNP denotes T
T13984 836-837 CD denotes +
T13983 833-836 NNP denotes CD4
T13982 826-832 JJ denotes normal
T13981 822-825 VBD denotes did
T13980 817-821 IN denotes than
T13979 811-816 NN denotes IL-10
T13978 805-810 NN denotes ng/ml
T13977 803-804 CD denotes 1
T13976 800-802 IN denotes of
T13975 791-799 NN denotes presence
T13974 787-790 DT denotes the
T13973 784-786 IN denotes in
T13972 778-783 NNP denotes IFN-γ
T13971 775-777 IN denotes of
T13970 768-774 NNS denotes levels
T13969 761-767 JJR denotes higher
T13968 752-760 VBD denotes produced
T13967 743-751 NNS denotes patients
T13966 740-742 NNP denotes RA
T13965 733-739 JJ denotes active
T13964 728-732 IN denotes from
T13963 722-727 NNS denotes cells
T13962 720-721 NNP denotes T
T13961 718-719 NNP denotes +
T13960 715-718 NNP denotes CD4
T13959 713-714 , denotes ,
T13958 702-713 NN denotes consequence
T13957 700-701 DT denotes a
T13956 697-699 IN denotes As
T13955 695-696 . denotes .
T13954 694-695 -RRB- denotes )
T13953 692-694 CD denotes 2b
T13952 687-691 NNP denotes Fig.
T13951 686-687 -LRB- denotes (
T13950 684-685 -RRB- denotes )
T13949 683-684 NN denotes %
T13948 680-683 CD denotes 7.9
T13947 678-679 NN denotes ±
T13946 673-677 CD denotes 65.8
T13945 671-672 , denotes ,
T13944 663-671 NNS denotes controls
T13943 661-662 : denotes ;
T13942 660-661 NN denotes %
T13941 656-660 CD denotes 14.4
T13940 654-655 NN denotes ±
T13939 649-653 CD denotes 45.6
T13938 647-648 , denotes ,
T13937 645-647 NNP denotes RA
T13936 636-644 JJ denotes inactive
T13935 634-635 : denotes ;
T13934 633-634 NN denotes %
T13933 629-633 CD denotes 14.4
T13932 627-628 NN denotes ±
T13931 623-626 CD denotes 2.9
T13930 621-622 , denotes ,
T13929 619-621 NNP denotes RA
T13928 612-618 JJ denotes active
T13927 610-611 : denotes :
T13926 602-610 NN denotes decrease
T13925 591-601 NN denotes percentage
T13924 590-591 -LRB- denotes (
T13923 581-589 NNS denotes controls
T13922 573-580 JJ denotes healthy
T13921 569-572 CC denotes and
T13920 563-568 NN denotes group
T13919 560-562 NNP denotes RA
T13918 551-559 JJ denotes inactive
T13917 547-550 DT denotes the
T13916 542-546 IN denotes with
T13915 533-541 VBN denotes compared
T13914 530-532 IN denotes as
T13913 524-529 NN denotes group
T13912 521-523 NNP denotes RA
T13911 514-520 JJ denotes active
T13910 510-513 DT denotes the
T13909 507-509 IN denotes in
T13908 499-506 VBN denotes limited
T13907 485-498 RB denotes significantly
T13906 481-484 VBD denotes was
T13905 470-480 NN denotes production
T13904 464-469 JJ denotes IFN-γ
T13903 461-463 IN denotes on
T13902 455-460 NN denotes IL-10
T13901 452-454 IN denotes of
T13900 445-451 NN denotes effect
T13899 434-444 JJ denotes inhibitory
T13898 430-433 DT denotes the
T13897 426-429 CC denotes but
T13896 424-425 , denotes ,
T13895 423-424 -RRB- denotes )
T13894 421-423 CD denotes 2a
T13893 416-420 NNP denotes Fig.
T13892 415-416 -LRB- denotes (
T13891 408-414 NNS denotes groups
T13890 402-407 CD denotes three
T13889 396-401 DT denotes these
T13888 390-395 IN denotes among
T13887 384-389 NN denotes IL-10
T13886 376-383 IN denotes without
T13885 365-375 NN denotes production
T13884 359-364 JJ denotes IFN-γ
T13883 356-358 IN denotes in
T13882 344-355 NNS denotes differences
T13881 332-343 JJ denotes significant
T13880 318-331 RB denotes statistically
T13879 315-317 DT denotes no
T13878 310-314 VBD denotes were
T13877 304-309 EX denotes There
T13876 302-303 . denotes .
T13875 294-302 NNS denotes controls
T13874 286-293 JJ denotes healthy
T13873 283-285 IN denotes in
T13872 279-282 CC denotes and
T13871 277-278 NNP denotes ]
T13870 275-277 CD denotes 26
T13869 274-275 NNP denotes [
T13868 272-273 -RRB- denotes )
T13867 268-272 NN denotes mg/l
T13866 265-267 CD denotes 10
T13865 263-264 NN denotes <
T13864 257-262 NN denotes level
T13863 253-256 NNP denotes CRP
T13862 251-252 , denotes ,
T13861 242-251 NN denotes remission
T13860 239-241 IN denotes in
T13859 238-239 -LRB- denotes (
T13858 230-237 NN denotes disease
T13857 221-229 JJ denotes inactive
T13856 217-220 CC denotes and
T13855 215-216 -RRB- denotes )
T13854 211-215 NN denotes mg/l
T13853 208-210 CD denotes 10
T13852 206-207 NN denotes
T13851 200-205 NN denotes level
T13850 196-199 NNP denotes CRP
T13849 194-195 , denotes ,
T13848 188-194 NNS denotes joints
T13847 175-187 JJ denotes inflammatory
T13846 166-174 JJ denotes multiple
T13845 165-166 -LRB- denotes (
T13844 157-164 NN denotes disease
T13843 150-156 JJ denotes active
T13842 145-149 IN denotes with
T13841 136-144 NNS denotes patients
T13840 133-135 NNP denotes RA
T13839 130-132 IN denotes in
T13838 124-129 NN denotes IL-10
T13837 118-123 NN denotes ng/ml
T13836 116-117 CD denotes 1
T13835 113-115 IN denotes of
T13834 104-112 NN denotes presence
T13833 100-103 DT denotes the
T13832 97-99 IN denotes in
T13831 83-96 NN denotes costimulation
T13830 78-82 NNP denotes CD28
T13829 74-77 CC denotes and
T13828 70-73 NNP denotes CD3
T13827 64-69 IN denotes after
T13826 58-63 NNS denotes cells
T13825 56-57 NNP denotes T
T13824 54-55 NNP denotes +
T13823 51-54 NNP denotes CD4
T13822 48-50 IN denotes by
T13821 37-47 NN denotes production
T13820 31-36 JJ denotes IFN-γ
T13819 28-30 IN denotes of
T13818 21-27 NNS denotes levels
T13817 17-20 DT denotes the
T13816 8-16 VBD denotes compared
T13815 3-7 RB denotes thus
T13814 0-2 PRP denotes We
T13991 855-856 . denotes .
T13990 854-855 -RRB- denotes )
T13989 852-854 CD denotes 2a
R7044 T13814 T13816 nsubj We,compared
R7045 T13815 T13816 advmod thus,compared
R7046 T13816 T13816 ROOT compared,compared
R7047 T13817 T13818 det the,levels
R7048 T13818 T13816 dobj levels,compared
R7049 T13819 T13818 prep of,levels
R7050 T13820 T13821 compound IFN-γ,production
R7051 T13821 T13819 pobj production,of
R7052 T13822 T13821 prep by,production
R7053 T13823 T13826 compound CD4,cells
R7054 T13824 T13826 compound +,cells
R7055 T13825 T13826 compound T,cells
R7056 T13826 T13822 pobj cells,by
R7057 T13827 T13816 prep after,compared
R7058 T13828 T13831 nsubj CD3,costimulation
R7059 T13829 T13828 cc and,CD3
R7060 T13830 T13828 conj CD28,CD3
R7061 T13831 T13827 pobj costimulation,after
R7062 T13832 T13831 prep in,costimulation
R7063 T13833 T13834 det the,presence
R7064 T13834 T13832 pobj presence,in
R7065 T13835 T13834 prep of,presence
R7066 T13836 T13838 nummod 1,IL-10
R7067 T13837 T13838 compound ng/ml,IL-10
R7068 T13838 T13835 pobj IL-10,of
R7069 T13839 T13838 prep in,IL-10
R7070 T13840 T13841 compound RA,patients
R7071 T13841 T13839 pobj patients,in
R7072 T13842 T13841 prep with,patients
R7073 T13843 T13844 amod active,disease
R7074 T13844 T13842 pobj disease,with
R7075 T13845 T13844 punct (,disease
R7076 T13846 T13848 amod multiple,joints
R7077 T13847 T13848 amod inflammatory,joints
R7078 T13848 T13844 appos joints,disease
R7079 T13849 T13844 punct ",",disease
R7080 T13850 T13851 compound CRP,level
R7081 T13851 T13852 nsubj level,≥
R7082 T13852 T13831 npadvmod ≥,costimulation
R7083 T13853 T13854 nummod 10,mg/l
R7084 T13854 T13852 appos mg/l,≥
R7085 T13855 T13852 punct ),≥
R7086 T13856 T13852 cc and,≥
R7087 T13857 T13858 amod inactive,disease
R7088 T13858 T13852 conj disease,≥
R7089 T13859 T13852 punct (,≥
R7090 T13860 T13852 prep in,≥
R7091 T13861 T13860 pobj remission,in
R7092 T13862 T13852 punct ",",≥
R7093 T13863 T13864 compound CRP,level
R7094 T13864 T13852 conj level,≥
R7095 T13865 T13867 nmod <,mg/l
R7096 T13866 T13867 nummod 10,mg/l
R7097 T13867 T13864 appos mg/l,level
R7098 T13868 T13864 punct ),level
R7099 T13869 T13871 nmod [,]
R7100 T13870 T13871 nummod 26,]
R7101 T13871 T13864 nmod ],level
R7102 T13872 T13827 cc and,after
R7103 T13873 T13827 conj in,after
R7104 T13874 T13875 amod healthy,controls
R7105 T13875 T13873 pobj controls,in
R7106 T13876 T13816 punct .,compared
R7107 T13877 T13878 expl There,were
R7108 T13878 T13878 ROOT were,were
R7109 T13879 T13882 det no,differences
R7110 T13880 T13881 advmod statistically,significant
R7111 T13881 T13882 amod significant,differences
R7112 T13882 T13878 attr differences,were
R7113 T13883 T13882 prep in,differences
R7114 T13884 T13885 amod IFN-γ,production
R7115 T13885 T13883 pobj production,in
R7116 T13886 T13882 prep without,differences
R7117 T13887 T13886 pobj IL-10,without
R7118 T13888 T13887 prep among,IL-10
R7119 T13889 T13891 det these,groups
R7120 T13890 T13891 nummod three,groups
R7121 T13891 T13888 pobj groups,among
R7122 T13892 T13893 punct (,Fig.
R7123 T13893 T13878 attr Fig.,were
R7124 T13894 T13893 nummod 2a,Fig.
R7125 T13895 T13893 punct ),Fig.
R7126 T13896 T13878 punct ",",were
R7127 T13897 T13878 cc but,were
R7128 T13898 T13900 det the,effect
R7129 T13899 T13900 amod inhibitory,effect
R7130 T13900 T13908 nsubjpass effect,limited
R7131 T13901 T13900 prep of,effect
R7132 T13902 T13901 pobj IL-10,of
R7133 T13903 T13902 prep on,IL-10
R7134 T13904 T13905 compound IFN-γ,production
R7135 T13905 T13903 pobj production,on
R7136 T13906 T13908 auxpass was,limited
R7137 T13907 T13908 advmod significantly,limited
R7138 T13908 T13878 conj limited,were
R7139 T13909 T13908 prep in,limited
R7140 T13910 T13913 det the,group
R7141 T13911 T13913 amod active,group
R7142 T13912 T13913 compound RA,group
R7143 T13913 T13909 pobj group,in
R7144 T13914 T13908 prep as,limited
R7145 T13915 T13914 prep compared,as
R7146 T13916 T13915 prep with,compared
R7147 T13917 T13920 det the,group
R7148 T13918 T13920 amod inactive,group
R7149 T13919 T13920 compound RA,group
R7150 T13920 T13916 pobj group,with
R7151 T13921 T13920 cc and,group
R7152 T13922 T13923 amod healthy,controls
R7153 T13923 T13920 conj controls,group
R7154 T13924 T13926 punct (,decrease
R7155 T13925 T13926 compound percentage,decrease
R7156 T13926 T13920 appos decrease,group
R7157 T13927 T13926 punct :,decrease
R7158 T13928 T13929 amod active,RA
R7159 T13929 T13926 acl RA,decrease
R7160 T13930 T13929 punct ",",RA
R7161 T13931 T13933 quantmod 2.9,14.4
R7162 T13932 T13933 quantmod ±,14.4
R7163 T13933 T13934 nummod 14.4,%
R7164 T13934 T13929 appos %,RA
R7165 T13935 T13937 punct ;,RA
R7166 T13936 T13937 amod inactive,RA
R7167 T13937 T13929 conj RA,RA
R7168 T13938 T13937 punct ",",RA
R7169 T13939 T13941 quantmod 45.6,14.4
R7170 T13940 T13941 quantmod ±,14.4
R7171 T13941 T13942 nummod 14.4,%
R7172 T13942 T13937 appos %,RA
R7173 T13943 T13937 punct ;,RA
R7174 T13944 T13937 conj controls,RA
R7175 T13945 T13944 punct ",",controls
R7176 T13946 T13948 quantmod 65.8,7.9
R7177 T13947 T13948 quantmod ±,7.9
R7178 T13948 T13949 nummod 7.9,%
R7179 T13949 T13944 appos %,controls
R7180 T13950 T13944 punct ),controls
R7181 T13951 T13937 punct (,RA
R7182 T13952 T13937 npadvmod Fig.,RA
R7183 T13953 T13952 nummod 2b,Fig.
R7184 T13954 T13937 punct ),RA
R7185 T13955 T13908 punct .,limited
R7186 T13956 T13968 prep As,produced
R7187 T13957 T13958 det a,consequence
R7188 T13958 T13956 pobj consequence,As
R7189 T13959 T13968 punct ",",produced
R7190 T13960 T13963 compound CD4,cells
R7191 T13961 T13963 compound +,cells
R7192 T13962 T13963 compound T,cells
R7193 T13963 T13968 nsubj cells,produced
R7194 T13964 T13963 prep from,cells
R7195 T13965 T13967 amod active,patients
R7196 T13966 T13967 compound RA,patients
R7197 T13967 T13964 pobj patients,from
R7198 T13968 T13968 ROOT produced,produced
R7199 T13969 T13970 amod higher,levels
R7200 T13970 T13968 dobj levels,produced
R7201 T13971 T13970 prep of,levels
R7202 T13972 T13971 pobj IFN-γ,of
R7203 T13973 T13968 prep in,produced
R7204 T13974 T13975 det the,presence
R7205 T13975 T13973 pobj presence,in
R7206 T13976 T13975 prep of,presence
R7207 T13977 T13978 nummod 1,ng/ml
R7208 T13978 T13979 compound ng/ml,IL-10
R7209 T13979 T13976 pobj IL-10,of
R7210 T13980 T13981 mark than,did
R7211 T13981 T13968 advcl did,produced
R7212 T13982 T13986 amod normal,cells
R7213 T13983 T13986 nmod CD4,cells
R7214 T13984 T13986 nummod +,cells
R7215 T13985 T13986 compound T,cells
R7216 T13986 T13981 nsubj cells,did
R7217 T13987 T13981 punct (,did
R7218 T13988 T13981 nsubj Fig.,did
R7219 T13989 T13988 nummod 2a,Fig.
R7220 T13990 T13988 punct ),Fig.
R7221 T13991 T13968 punct .,produced

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T13055 847-854 Protein denotes Fig. 2a
T13054 833-837 Protein denotes CD4+
T13053 778-783 Protein denotes IFN-γ
T13052 715-719 Protein denotes CD4+
T13051 470-480 Gene_expression denotes production
T13050 470-480 Gene_expression denotes production
T13049 365-375 Gene_expression denotes production
T13048 365-375 Gene_expression denotes production
T13047 464-469 Protein denotes IFN-γ
T13046 455-460 Protein denotes IL-10
T13045 416-423 Protein denotes Fig. 2a
T13044 359-364 Protein denotes IFN-γ
T13043 37-47 Gene_expression denotes production
T13042 253-256 Protein denotes CRP
T13041 196-199 Protein denotes CRP
T13040 78-82 Protein denotes CD28
T13039 70-73 Protein denotes CD3
T13038 51-55 Protein denotes CD4+
T13037 31-36 Protein denotes IFN-γ
R6408 T13037 T13043 themeOf IFN-γ,production
R6409 T13044 T13048 themeOf IFN-γ,production
R6410 T13045 T13049 themeOf Fig. 2a,production
R6411 T13046 T13050 themeOf IL-10,production
R6412 T13047 T13051 themeOf IFN-γ,production

test3

Id Subject Object Predicate Lexical cue
T12290 833-836 Protein denotes CD4
T12289 811-816 Protein denotes IL-10
T12288 778-783 Protein denotes IFN-γ
T12287 752-760 Gene_expression denotes produced
T12286 715-718 Protein denotes CD4
T12285 470-480 Gene_expression denotes production
T12284 464-469 Protein denotes IFN-γ
T12283 455-460 Protein denotes IL-10
T12282 445-451 Regulation denotes effect
T12281 384-389 Protein denotes IL-10
T12280 365-375 Gene_expression denotes production
T12279 359-364 Protein denotes IFN-γ
T12278 124-129 Protein denotes IL-10
T12277 78-82 Protein denotes CD28
T12276 70-73 Protein denotes CD3
T12275 51-54 Protein denotes CD4
T12274 37-47 Gene_expression denotes production
T12273 31-36 Protein denotes IFN-γ
T12234 833-836 Protein denotes CD4
T12233 811-816 Protein denotes IL-10
T12232 778-783 Protein denotes IFN-γ
T12231 715-718 Protein denotes CD4
T12230 464-469 Protein denotes IFN-γ
T12229 455-460 Protein denotes IL-10
T12228 384-389 Protein denotes IL-10
T12227 359-364 Protein denotes IFN-γ
T12226 124-129 Protein denotes IL-10
T12225 78-82 Protein denotes CD28
T12224 70-73 Protein denotes CD3
T12223 51-54 Protein denotes CD4
T12222 31-36 Protein denotes IFN-γ
R6344 T12273 T12274 themeOf IFN-γ,production
R6345 T12279 T12280 themeOf IFN-γ,production
R6346 T12283 T12285 themeOf IL-10,production
R6347 T12284 T12285 themeOf IFN-γ,production
R6348 T12285 T12282 themeOf production,effect
R6349 T12288 T12287 themeOf IFN-γ,produced

testone

Id Subject Object Predicate Lexical cue
T12168 761-767 Positive_regulation denotes higher
T12167 752-760 Gene_expression denotes produced
T12166 499-506 Negative_regulation denotes limited
T12165 470-480 Gene_expression denotes production
T12164 445-451 Regulation denotes effect
T12163 434-444 Negative_regulation denotes inhibitory
T12162 365-375 Gene_expression denotes production
T12161 37-47 Gene_expression denotes production
T12145 833-836 Protein denotes CD4
T12144 811-816 Protein denotes IL-10
T12143 778-783 Protein denotes IFN-γ
T12142 715-718 Protein denotes CD4
T12141 464-469 Protein denotes IFN-γ
T12140 455-460 Protein denotes IL-10
T12139 384-389 Protein denotes IL-10
T12138 359-364 Protein denotes IFN-γ
T12137 124-129 Protein denotes IL-10
T12136 78-82 Protein denotes CD28
T12135 70-73 Protein denotes CD3
T12134 51-54 Protein denotes CD4
T12133 31-36 Protein denotes IFN-γ
R6311 T12133 T12161 themeOf IFN-γ,production
R6312 T12138 T12162 themeOf IFN-γ,production
R6313 T12141 T12165 themeOf IFN-γ,production
R6314 T12143 T12167 themeOf IFN-γ,produced
R6315 T12143 T12168 themeOf IFN-γ,higher
R6316 T12144 T12168 causeOf IL-10,higher
R6323 T12165 T12166 themeOf production,limited
R6324 T12165 T12164 themeOf production,effect
R6325 T12167 T12168 themeOf produced,higher